1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, February 2017

Biological Therapy Analysis & Statistics, February 2017

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

1-30 of about 1000 reports

Purchase Reports From Reputable Market Research Publishers

Autologous Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Autologous Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Autologous Cell Therapy Market: Overview This report provides in-depth region wise and country wise analysis of the autologous cell therapy market. Stakeholders of this report include manufacturers ...

  • Industries : Biological Therapy
  • Countries : World
Regenerative Medicine Market by Therapy, Product, Applications - Forecast to 2021

Regenerative Medicine Market by Therapy, Product, Applications - Forecast to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

“Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), By Product (Cell-Based, Acellular), By Applications (Orthopedic & Musculoskeletal Disorders, ...

  • Industries : Biological Therapy, Biotechnology, Genomics
  • Countries : World, Europe, North America, United States
Top 10 Bioprocess Technology Market by Cell Culture, Cell Expansion, Cell Counting, Cell Line Development, Flow Cytometry, Single-Use Bioprocessing, Biologics Safety Testing, Tangential Flow Filtration, Virus Filtration & Region - Forecast to 2021

Top 10 Bioprocess Technology Market by Cell Culture, Cell Expansion, Cell Counting, Cell Line Development, Flow Cytometry, Single-Use Bioprocessing, Biologics Safety Testing, Tangential Flow Filtration, Virus Filtration & Region - Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global top 10 bioprocess technology market is expected to reach USD 71.03 billion by 2021 from USD 39.30 billion in 2016, at a CAGR of 12.4% from 2016 to 2021. On the basis of type, the market is segmented ...

  • Industries : Biotechnology, Biological Therapy, In Vitro Diagnostics, Biopharmaceutical, Medical Device
  • Countries : World
Top 10 Cellular Analysis Market by Technology, Application & End User - Global Forecast to 2021

Top 10 Cellular Analysis Market by Technology, Application & End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The top 10 cellular analysis market is expected to reach USD 41.34 billion by 2021 from USD 28.66 billion in 2016, at a CAGR of 7.6% during the forecast period. Factors such as increasing government support ...

  • Industries : Healthcare
  • Countries : Europe, Asia, World, North America, United States
Transfection Reagents and Equipment Market by Method, Physical, Viral, Application, End User - Global Forecast to 2021

Transfection Reagents and Equipment Market by Method, Physical, Viral, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global transfection reagents and equipment market is expected to reach USD 1.02 billion by 2021 from USD 715.4 million in 2016, at a CAGR of 7.5% during the forecast period 2016 to 2021. Over the years, ...

  • Industries : Biotechnology, Genetically Modified Organism
  • Countries : World, Asia, Europe, North America
Cartilage Repair/ Cartilage Regeneration Market by Treatment modalities, Application, Region - Forecast to 2021

Cartilage Repair/ Cartilage Regeneration Market by Treatment modalities, Application, Region - Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global cartilage repair/ cartilage regeneration market is projected to reach USD 779.8 million by 2021 from USD 414.6 million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 ...

  • Industries : Biological Therapy
  • Countries : World, Asia, United States, Europe, North America
High-Throughput Screening Market by Technology, Application, Product, End User - Forecast to 2021

High-Throughput Screening Market by Technology, Application, Product, End User - Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The high-throughput screening (HTS) market is expected to grow at a lucrative CAGR of 7.8% from 2016 to 2021, to reach USD 18.83 billion by 2021 from USD 12.23 billion in 2016. Market growth can be attributed ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : Europe, World, North America, United States, Asia
Global Single-Cell Analysis Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights By Type of Product, by Type of Cell, by Type of Technique, by Application and by End User

Global Single-Cell Analysis Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights By Type of Product, by Type of Cell, by Type of Technique, by Application and by End User

  • $ 5100
  • Industry report
  • December 2016
  • by P&S Market Research

The global single-cell analysis market is witnessing high growth due to increasing geriatric population, high prevalence of infectious diseases, growing focus on personalized medicines, and technological ...

  • Industries : Biological Therapy, In Vitro Diagnostics, Pathology
  • Countries : World
Global Regenerative Medicine - Pharmaceuticals

Global Regenerative Medicine - Pharmaceuticals

  • $ 4950
  • Industry report
  • January 2017
  • by Global Industry Analysts

This report analyzes the worldwide markets for Regenerative Medicine in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual ...

  • Industries : Biological Therapy, Biotechnology, Genomics
  • Countries : World, United States
Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast-2023

Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Growth Hormone Deficiency (GHD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Growth Hormone Deficiency ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
  • Countries : United States, World, Japan
Cell Analysis Global Market  – Forecast To 2023

Cell Analysis Global Market – Forecast To 2023

  • $ 4950
  • Industry report
  • January 2017
  • by IQ4I Research & Consultancy Pvt. Ltd

Cells are the biological units that are used for the identification and mapping of the basic biochemical and physical processes of life. Analysis of these cells plays a major role in gene identification, ...

  • Industries : Biotechnology, Biological Therapy
  • Countries : World
Drug And Gene Delivery Devices Market Analysis By Drug Delivery Type (Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical), By Gene Delivery Vector (Viral, Non-viral), By Gene Delivery Type (In situ, Ex vivo), And Segment Forecasts, 2014 - 2

Drug And Gene Delivery Devices Market Analysis By Drug Delivery Type (Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical), By Gene Delivery Vector (Viral, Non-viral), By Gene Delivery Type (In situ, Ex vivo), And Segment Forecasts, 2014 - 2

  • $ 4950
  • Industry report
  • December 2016
  • by Grand View Research

The global drug and gene delivery systems market is expected to reach USD 786.9 Billion by 2025, according to a new report by Grand View Research, Inc. Rising investment by the market players to develop ...

  • Industries : Drug Delivery, Biological Therapy
Global Single Cell Analysis Market Analysis & Trends - Industry Forecast to 2025

Global Single Cell Analysis Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • January 2017
  • by Accuray Research LLP

The Global Single Cell Analysis Market is poised to grow at a CAGR of around 18.9% over the next decade to reach approximately $6.92 billion by 2025. Some of the prominent trends that the market is witnessing ...

  • Industries : Biological Therapy
  • Countries : World, United States
Global Stem Cell Therapy Market 2017-2021

Global Stem Cell Therapy Market 2017-2021

  • $ 3500
  • Industry report
  • January 2017
  • by Infiniti Research Limited

About stem cell therapy Stem cell therapy is the use of stem cells for the treatment or prevention of a disease or condition. Bone marrow transplant is the widely-used stem cell therapy, followed by therapies ...

  • Industries : Biological Therapy
  • Countries : Japan, World
2017-2021 Emerging Opportunities in the Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape

2017-2021 Emerging Opportunities in the Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape

  • $ 3500
  • Industry report
  • February 2017
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, France, Italy, United Kingdom, Japan
2017-2021 Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

2017-2021 Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 3500
  • Industry report
  • January 2017
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, France, Italy, United Kingdom, Japan
Hemagglutinin 5 (H5) - Pipeline Review, H2 2016

Hemagglutinin 5 (H5) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Hemagglutinin 5 (H5) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hemagglutinin 5 (H5) - Pipeline Review, H2 2016’, provides in depth analysis on Hemagglutinin 5 (H5) targeted pipeline ...

  • Industries : Pathology
  • Countries : United States
Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H2 2016

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, ...

  • Industries : Cancer, Pathology, Biological Therapy, Therapy
  • Countries : Europe, World
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline Review, H2 2016

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline ...

  • Industries : Biological Therapy, Pathology, Therapy
  • Countries : France, World, United States, Europe
Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H2 2016

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H2 2016 Summary Global ...

  • Industries : Therapy, Pathology, Biological Therapy
  • Countries : United States
Interleukin 12 Receptor (IL12R) - Pipeline Review, H2 2016

Interleukin 12 Receptor (IL12R) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Interleukin 12 Receptor (IL12R) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 12 Receptor (IL12R) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin ...

  • Industries : Biological Therapy, Therapy
  • Countries : United States
Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Pipeline Review, H2 2016

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase ...

  • Industries : Therapy, Biopharmaceutical, Pathology, Pharmaceutical
  • Countries : United States, World
Interleukin 15 (IL15) - Pipeline Review, H2 2016

Interleukin 15 (IL15) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Interleukin 15 (IL15) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 15 (IL15) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 15 (IL15) targeted ...

  • Industries : Pathology, Biological Therapy, Therapy
  • Countries : United States, World
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2016

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 1 Receptor Associated ...

  • Industries : Biological Therapy, Pathology, Therapy, Cancer, Pharmaceutical
  • Countries : United States
Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Pipeline Review, H2 2016

Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Pipeline Review, H2 2016’, ...

  • Industries : Cancer, Therapy, Pathology, Biological Therapy
  • Countries : United States
Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016 Summary Global Markets ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016

HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016’, provides in depth analysis on HIV 1 Integrase (EC ...

  • Industries : Therapy
  • Countries : United States
Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2016

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Granulocyte Macrophage Colony Stimulating ...

  • Industries : Biological Therapy, Therapy, Biotechnology, Pathology
  • Countries : United States
2016-2021  World Cell Surface Marker Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

2016-2021 World Cell Surface Marker Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 3500
  • Industry report
  • November 2016
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, France, Italy, United Kingdom, Japan
Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H2 2016

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Cancer, Pathology, Biological Therapy
  • Countries : United States
About 4000 reports

Download Unlimited Documents from Trusted Public Sources

Biological Therapy Industry in the US

  • February 2017
    11 pages
  • Biological Ther...  

    Biotechnology  

  • United States  

    United Kingdom  

View report >

Cytokine Supply

February 2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.